Soleno Therapeutics Inc (NASDAQ:SLNO)
| 5.70 Delayed Data As of Jun 09 |  -0.30 / -5.00%Today’s Change | 0.85 Today|||52-Week Range 6.20 | +187.88% Year-to-Date |
Latest SLNO News | Press Releases
No recent news for Soleno Therapeutics Inc.
Today’s Trading
| Previous close | 6.00 |
| Today’s open | 5.97 |
| Day’s range | 5.70 - 5.97 |
| Volume | 1,001 |
| Average volume (3 months) | 87,496 |
| Market cap | $32.3M |
Data as of 3:59pm ET, 06/09/2023
Growth & Valuation
| Earnings growth (last year) | +50.69% |
| Earnings growth (this year) | +18.29% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 4.68 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MEIPMEI Pharma Inc | 0.00 | 0.00% |
| SLSSellas Life Sciences... | -0.03 | -1.78% |
| BYSIBeyondspring Inc | +0.05 | +4.13% |
| GNPXGenprex Inc | -0.00 | -0.23% |
Data as of 3:59pm ET, 06/09/2023
Financials
| Next reporting date | August 10, 2023 |
| EPS forecast (this quarter) | -$0.80 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$24.1M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Redwood City, California |
Forecasts
